American Journal of Kidney Diseases最新文献

筛选
英文 中文
Peripheral Neuropathy Presenting With Hypereosinophilia: A Quiz 以嗜酸性细胞增多症为表现的周围神经病变:一个小测验
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-19 DOI: 10.1053/j.ajkd.2025.01.017
Rex K. Siu , Alexandra C. Hardy , Faaiq N. Aslam , Induja R. Nimma , Sehreen Mumtaz , Sam T. Albadri , Nancy Dawson , Lyle W. Baker
{"title":"Peripheral Neuropathy Presenting With Hypereosinophilia: A Quiz","authors":"Rex K. Siu , Alexandra C. Hardy , Faaiq N. Aslam , Induja R. Nimma , Sehreen Mumtaz , Sam T. Albadri , Nancy Dawson , Lyle W. Baker","doi":"10.1053/j.ajkd.2025.01.017","DOIUrl":"10.1053/j.ajkd.2025.01.017","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"86 1","pages":"Pages A13-A16"},"PeriodicalIF":9.4,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144320893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply to "Clarification on Existing Opportunities for POCUS Certifications for Nephrologists". 回复“关于肾脏科医师POCUS认证的现有机会的澄清”。
IF 13.2 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-16 DOI: 10.1053/j.ajkd.2025.04.016
Abhilash Koratala,Amir Kazory
{"title":"In Reply to \"Clarification on Existing Opportunities for POCUS Certifications for Nephrologists\".","authors":"Abhilash Koratala,Amir Kazory","doi":"10.1053/j.ajkd.2025.04.016","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.016","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"13 1","pages":""},"PeriodicalIF":13.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why Do Creatinine- and Cystatin C-Based Estimated GFR Values Often Differ? 为什么基于肌酐和胱抑素c的GFR估计值经常不同?
IF 13.2 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-16 DOI: 10.1053/j.ajkd.2025.05.002
Antoine Créon,Andrew S Levey,Juan J Carrero
{"title":"Why Do Creatinine- and Cystatin C-Based Estimated GFR Values Often Differ?","authors":"Antoine Créon,Andrew S Levey,Juan J Carrero","doi":"10.1053/j.ajkd.2025.05.002","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.05.002","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"5 1","pages":""},"PeriodicalIF":13.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144295799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clarification on Existing Opportunities for POCUS Certifications for Nephrologists. 澄清肾脏科医师POCUS认证的现有机会。
IF 13.2 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-16 DOI: 10.1053/j.ajkd.2025.04.015
Daniel W Ross,Andrew A Moses,Adina S Voiculescu,Vandana Dua Niyyar
{"title":"Clarification on Existing Opportunities for POCUS Certifications for Nephrologists.","authors":"Daniel W Ross,Andrew A Moses,Adina S Voiculescu,Vandana Dua Niyyar","doi":"10.1053/j.ajkd.2025.04.015","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.015","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":"145 1","pages":""},"PeriodicalIF":13.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144319816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Financial Nephrotoxicity: Prevention Is Better Than Cure. 金融肾毒性:预防胜于治疗。
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-13 DOI: 10.1053/j.ajkd.2025.05.001
Simon Sawhney, Nicole Scholes-Robertson
{"title":"Financial Nephrotoxicity: Prevention Is Better Than Cure.","authors":"Simon Sawhney, Nicole Scholes-Robertson","doi":"10.1053/j.ajkd.2025.05.001","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.05.001","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144281957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reframing Risk in CKD: Inflammation at the Center Stage. 慢性肾病的风险重构:炎症处于中心阶段。
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-12 DOI: 10.1053/j.ajkd.2025.04.010
Peter Stenvinkel
{"title":"Reframing Risk in CKD: Inflammation at the Center Stage.","authors":"Peter Stenvinkel","doi":"10.1053/j.ajkd.2025.04.010","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.010","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Stay or to Fold: Biomarkers and the Management of Potentially Hemodynamic Acute Kidney Injury. 留还是走:生物标志物和潜在的血流动力学急性肾损伤的管理。
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-11 DOI: 10.1053/j.ajkd.2025.04.006
Justin M Belcher
{"title":"To Stay or to Fold: Biomarkers and the Management of Potentially Hemodynamic Acute Kidney Injury.","authors":"Justin M Belcher","doi":"10.1053/j.ajkd.2025.04.006","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.006","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality on Hemodiafiltration Compared to High-Flux Hemodialysis: A Brazilian Cohort Study. 血液滤过与高通量血液透析的死亡率比较:一项巴西队列研究。
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-09 DOI: 10.1053/j.ajkd.2025.04.013
Jorge Paulo Strogoff-de-Matos, Maria Eugenia F Canziani, Ana Beatriz L Barra
{"title":"Mortality on Hemodiafiltration Compared to High-Flux Hemodialysis: A Brazilian Cohort Study.","authors":"Jorge Paulo Strogoff-de-Matos, Maria Eugenia F Canziani, Ana Beatriz L Barra","doi":"10.1053/j.ajkd.2025.04.013","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.013","url":null,"abstract":"<p><strong>Rationale & objective: </strong>Hemodiafiltration (HDF) has been associated with better survival than high flux hemodialysis (HD), but these studies were mainly conducted in developed countries. This study examined the mortality risk among Brazilian patients with kidney failure, comparing treatment with HDF to treatment with high-flux HD.</p><p><strong>Study design: </strong>Observational cohort study.</p><p><strong>Setting & participants: </strong>All adult patients on maintenance dialysis (high-flux HD and HDF) at 29 dialysis facilities in Brazil between January 1, 2022 and December 31, 2023.</p><p><strong>Exposure: </strong>Treatment with HDF patients versus high-flux HD.</p><p><strong>Outcome: </strong>All-cause mortality and cause-specific mortality attributed to cardiovascular/cerebrovascular and infection-related diseases.</p><p><strong>Analytical approach: </strong>Multivariable Cox proportional hazards regression in which dialysis modality was considered a time-updated exposure.</p><p><strong>Results: </strong>8,391 patients were included in the study: 6,787 receiving only high-flux HD, 2,836 receiving HDF, among whom 1,222 had migrated from high-flux HD to HDF during the follow-up period. The two-year survival rates in these groups were 81.2% and 77.9%, respectively (p < 0.001). A significantly lower adjusted death risk was observed among patients receiving HDF versus HD (HR 0.73; 95% confidence interval [CI], 0.63-0.85) in a time-updated analysis. HDF treatment was also associated with the reduction of cardiovascular mortality risk, but not of infection-related death. In the subgroup analysis, the reduction in mortality risk associated with HDF was consistent across subgroups, with a more pronounced effect observed in patients under the age of 65 (HR, 0.56; 95% CI, 0.42-0.77) than for those aged 65 or more (HR, 0.82; 95% CI, 0.70-0.96). In a sensitivity analysis, including only HD and HDF as starting therapy and data censored at the time of dialysis modality change, treatment with HDF was associated with a lower death risk (HR 0.73; 95% CI, 0.62-0.85).</p><p><strong>Limitations: </strong>The retrospective design and a relatively small follow-up period.</p><p><strong>Conclusions: </strong>In this large cohort study conducted in Brazil, patients treated with HDF, compared to those on conventional high-flux HD, exhibited a lower risk of all-cause and cardiovascular mortality.</p>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease. 成人动脉粥样硬化性心血管疾病的全身性炎症和不良肾脏结局的风险
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-06 DOI: 10.1053/j.ajkd.2025.04.011
Faizan Mazhar, Edouard L Fu, Anne-Laure Faucon, Paul Hjemdahl, Jimmi Mathisen, Iram Faqir Muhammad, Oscar Plunde, Vlado Perkovic, Katherine R Tuttle, Juan-Jesus Carrero
{"title":"Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular Disease.","authors":"Faizan Mazhar, Edouard L Fu, Anne-Laure Faucon, Paul Hjemdahl, Jimmi Mathisen, Iram Faqir Muhammad, Oscar Plunde, Vlado Perkovic, Katherine R Tuttle, Juan-Jesus Carrero","doi":"10.1053/j.ajkd.2025.04.011","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.04.011","url":null,"abstract":"<p><strong>Rationale & objective: </strong>Inflammasome activation is involved in the pathogenesis of both atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD). This study investigated whether systemic inflammation, measured by C-reactive protein (CRP), is associated with adverse kidney outcomes in adults with ASCVD.</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Setting & participants: </strong>83,928 adults with ASCVD in Stockholm, Sweden, who underwent routine CRP testing between 2007 and 2021.</p><p><strong>Exposure(s): </strong>CRP was defined as the geometric mean of serum CRP levels within a 3-month ascertainment window, excluding CRP values potentially associated with an acute inflammatory process.</p><p><strong>Outcome(s): </strong>AKI (based on diagnosis code or KDIGO serum creatinine criteria) and a composite kidney outcome defined as sustained >30% decline in eGFR or kidney failure.</p><p><strong>Analytical approach: </strong>Cause-specific Cox proportional hazards regression.</p><p><strong>Results: </strong>54% of the cohort was male, with mean age of 71 years. 59% of participants had systemic inflammation (CRP ≥2 mg/L). Over a median follow-up of 6.4 years (interquartile range, 3.1-9.8 years), 8371 kidney events, 10,757 AKI events, and 24,954 deaths were recorded. Compared with CRP <1 mg/L, higher CRP categories were associated with increased risks of both outcomes. Compared to a CRP of 1 or less, the adjusted HRs for the composite kidney outcome were 1.16 (95% CI, 1.09-1.23) for CRP >1-3 mg/L, 1.24 (1.17-1.32) for CRP >3-10 mg/L, and 1.35 (1.25-1.46) for CRP >10-20 mg/L. For AKI, the HRs were 1.18 (1.12-1.25), 1.34 (1.27-1.42), and 1.37 (1.28-1.47), respectively.</p><p><strong>Limitations: </strong>Unmeasured confounding inherent to observational studies.</p><p><strong>Conclusions: </strong>In this large cohort of adults with ASCVD, elevated CRP levels were associated with higher risks of adverse kidney outcomes.</p>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplant Staff Awareness of Gender Disparities and the Evaluation of Women for Kidney Transplantation. 移植人员对性别差异的认识及对女性肾移植的评价。
IF 9.4 1区 医学
American Journal of Kidney Diseases Pub Date : 2025-06-06 DOI: 10.1053/j.ajkd.2025.03.027
Annika Gompers, Jade Buford, Rachel E Patzer, Stephen O Pastan, Ana Rossi, Jessica L Harding
{"title":"Transplant Staff Awareness of Gender Disparities and the Evaluation of Women for Kidney Transplantation.","authors":"Annika Gompers, Jade Buford, Rachel E Patzer, Stephen O Pastan, Ana Rossi, Jessica L Harding","doi":"10.1053/j.ajkd.2025.03.027","DOIUrl":"https://doi.org/10.1053/j.ajkd.2025.03.027","url":null,"abstract":"","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":" ","pages":""},"PeriodicalIF":9.4,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144245734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信